Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS

Neoplasma

Volumn 61, Issue 1, 2014, Pages 17-26

  He, X ^a   Wang, Y ^a   Zhang, W ^b   Li, H ^a   Luo, R ^a   Zhou, Y ^a   Li, C ^a   Liao, M ^a   Huang, H ^a   Lv, X ^b   Xie, Z ^a   He, M ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

AFP Negative; GSN; HCC; iTRAQ

Indexed keywords

ALPHA FETOPROTEIN; GELSOLIN; PLASMA PROTEIN;

ADULT; ARTICLE; CANCER SCREENING; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; FUNCTIONAL PROTEOMICS; GENE ONTOLOGY; HEPATITIS B VIRUS; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOBARIC TAGS FOR THE RELATIVE AND ABSOLUTE QUANTIZATION; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; ALPHA-FETOPROTEINS; BLOOD PROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84893172966     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_001     Document Type: Article

References (47)

1. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-917. http://dx.doi.org/10.1002/ijc.25516
2. NGUYEN VT, LAW MG, DORE GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009; 16: 453-63. http://dx.doi.org/10.1111/j.1365-2893.2009.01117.x
3. SHERMAN M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010; 30: 3-16. http://dx.doi.org/10.1055/s-0030-1247128
4. TANG ZY, YU YQ, ZHOU XD, MA ZC, YANG BH, et al. Analysis of one hundred and twenty five patients with primary liver cancer surviving more than five years. Gan To Kagaku Ryoho.1992; 19: 1202-6.
5. CATURELLI E, BARTOLUCCI F, BIASINI E, VIGLIOTTI ML, ANDRIULLI A, et al. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol. 2002; 97: 397-405. http://dx.doi.org/10.1111/j.1572-0241.2002.05477.x
6. ALVAREZ D, ANDERS M, MELLA J, AMANTE M, OROZCO F, et al. [Usefulness of transient elastography (Fibroscan(R) in the assessment of fibrosis in patients with chronic liver disease]. Medicina (B Aires). 2012; 72: 10-4.
7. El-Aneed A, Banoub J. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients. Anticancer Res. 2006; 26: 3293-300.
8. ZHANG G, HA SA, KIM HK, YOO J, KIM S, et al. Combined analysis of AFP and HCCR-1 as an useful serological marker for small hepatocellular carcinoma: a prospective cohort study. Dis Markers. 2012; 32: 265-71. http://dx.doi.org/10.1155/2012/964036
9. XU J, LIU C, ZHOU L, TIAN F, TAI MH, et al. Distinctions between clinicopathological factors and prognosis of alphafetoprotein negative and positive hepatocelluar carcinoma patients. Asian Pac J Cancer Prev. 2012; 13: 559-62. http://dx.doi.org/10.7314/APJCP.2012.13.2.559
10. MARINGHINI A, COT TONE M, SCIARRINO E, MARCENO MP, LA SETA F, et al. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci. 1988; 33: 47-51. http://dx.doi.org/10.1007/BF01536630
11. LOK AS, LAI CL. alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989; 9: 110-5. http://dx.doi.org/10.1002/hep.1840090119
12. CARR SA, ANDERSON L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin Chem. 2008; 54: 1749-52. http://dx.doi.org/10.1373/clinchem.2008.114686
13. AVASARALA JR, WALL MR, WOLFE GM. A distinctive molecular signature of multiple sclerosis derived from MALDI-TOF/MS and serum proteomic pattern analysis: detection of three biomarkers. J Mol Neurosci. 2005; 25: 119-25. http://dx.doi.org/10.1385/JMN:25:1:119
14. DRAKE PM, SCHILLING B, NILES RK, BRATEN M, JOHANSEN E, et al. A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma. Anal Biochem. 2011; 408; 71-85. http://dx.doi.org/10.1016/j.ab.2010.08.010
15. SHORES KS, KNAPP DR. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J Proteome Res. 2007; 6: 3739-51. http://dx.doi.org/10.1021/pr070293w
16. LATTERICH M, ABRAMOVITZ M, LEYLAND-JONES B. Proteomics: new technologies and clinical applications. Eur J Cancer. 2008; 44: 2737-41. http://dx.doi.org/10.1016/j.ejca.2008.09.007
17. CHEN X, SUN L, YU Y, XUE Y, YANG P. Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev Proteomics. 2007; 4: 25-37. http://dx.doi.org/10.1586/14789450.4.1.25
18. ZUBEROVIC A, WETTERHALL M, HANRIEDER J, BERGQUIST J. CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid. Electrophoresis. 2009; 30: 1836-43. http://dx.doi.org/10.1002/elps.200800714
19. TREMOSINI S, FORNER A, BOIX L, VILANA R, BIANCHI L, et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. 2012; 61:1481-7. http://dx.doi.org/10.1136/gutjnl-2011-301862
20. MATHEWS ST, PLAISANCE EP, KIM T. Imaging systems for westerns: chemiluminescence vs. infrared detection. Methods Mol Biol. 2009; 536: 499-513. http://dx.doi.org/10.1007/978-1-59745-542-8_51
21. HUANG HL, STASYK T, MORANDELL S, DIEPLINGER H, FALKENSAMMER G, et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis. 2006; 27: 1641-50. http://dx.doi.org/10.1002/elps.200500857
22. CHONG PK, GAN CS, PHAM TK, WRIGHT PC. Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections. J Proteome Res. 2006; 5: 1232-40. http://dx.doi.org/10.1021/pr060018u
23. ZHANG F, CHEN JY. Discovery of pathway biomarkers from coupled proteomics and systems biology methods. BMC genomics. 2010; 11 Suppl 2: S12. http://dx.doi.org/10.1186/1471-2164-11-S2-S12
24. LIN ZY, CHUANG WL, CHUANG YH. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines. European journal of clinical investigation. 2009; 39: 239-45. http://dx.doi.org/10.1111/j.1365-2362.2008.02066.x
25. SCHWARZBAUER JE, DESIMONE DW. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol. 2011; 3. 26 Wang F, Song G, Liu M, Li X, Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS letters. 2011; 585: 3263-9. http://dx.doi.org/10.1016/j.febslet.2011.08.052
26. ZHAO J, ZHAI W, ZHANG Y. [Expression of integrin alpha 5, beta 1 subunit and fibronectin mRNAs in human hepatocellular carcinoma]. Zhonghua Bing Li Xue Za Zhi.1998; 27: 94-8.
27. MOTTA G, ROJKJAER R, HASAN AA, CINES DB, SCHMAIER AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood. 1998; 91: 516-28.
28. RITHIDECH KN, HONIKEL L, RIEGER R, XIE W, FISCHER T, et al. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays. International journal of radiation biology. 2009; 85: 432-47. http://dx.doi.org/10.1080/09553000902820390
29. LINDEN M, LIND SB, MAYRHOFER C, SEGERSTEN U, WESTER K, et al. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. Proteomics. 2012; 12: 135-44. http://dx.doi.org/10.1002/pmic.201000810
30. SANDANAYAKE NS, SINCLAIR J, ANDREOLA F, CHAPMAN MH, XUE A, et al. A combination of serum leucine-rich alpha-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. Br J Cancer. 2011; 105: 1370-8. http://dx.doi.org/10.1038/bjc.2011.376
31. POON IK, PATEL KK, DAVIS DS, PARISH CR, HULETT MD. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood. 2011; 117: 2093-101. http://dx.doi.org/10.1182/blood-2010-09-303842
32. ROLNY C, MAZZONE M, TUGUES S, LAOUI D, JOHANSSON I, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell. 2011; 19: 31-44. http://dx.doi.org/10.1016/j.ccr.2010.11.009
33. YOSHIOKA T, NISHIKAWA Y, ITO R, KAWAMATA M, DOI Y, et al. Significance of integrin alphavbeta5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin. Cancer Sci. 2010; 101: 2011-8. http://dx.doi.org/10.1111/j.1349-7006.2010.01640.x
34. LIU Y, HE J, LI C, BENITEZ R, FU S, et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J Proteome Res. 2010; 9: 798-805. http://dx.doi.org/10.1021/pr900715p
35. HU RH, LEE PH, YU SC. Secretion of acute-phase proteins before and after hepatocellular carcinoma resection. J Formos Med Assoc. 1999; 98: 85-91.
36. SIEGHART W, PINTER M, HUCKE F, GRAZIADEI I, SCHONIGER-HEKELE M, et al. A single determination of C-reactive protein at the time of diagnosis predicts long term outcome of patients with hepatocellular carcinoma. Hepatology. 2012.
37. GUTFELD O, PRUS D, ACKERMAN Z, DISHON S, LINKE RP, et al. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem. 2006; 54: 63-73. http://dx.doi.org/10.1369/jhc.5A6645.2005
38. SHU H, KANG X, GUO K, LI S, LI M, et al. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein. Oncol Rep. 2010; 24: 1271-6.
39. AZUMA T, KOTHS K, FLANAGAN L, KWIATKOWSKI D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and-9 to retard apoptotic progression. J Biol Chem. 2000; 275: 3761-6. http://dx.doi.org/10.1074/jbc.275.6.3761
40. AN JH, KIM JW, JANG SM, KIM CH, KANG EJ, et al. Gelsolin negatively regulates the activity of tumor suppressor p53 through their physical interaction in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun. 2011; 412: 44-9. http://dx.doi.org/10.1016/j.bbrc.2011.07.034
41. GUR-DEDEOGLU B, KONU O, BOZKURT B, ERGUL G, SECKIN S, et al. Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues. Oncol Res. 2009; 17: 353-65. http://dx.doi.org/10.3727/096504009788428460
42. BROCK R, XIONG B, LI L, VANBOGELEN RA, CHRISTMAN L. A multiplex serum protein assay for determining the probability of colorectal cancer. Am J Cancer Res. 2012; 2: 598-605.
43. KLOTH JN, GORTER A, FLEUREN GJ, OOSTING J, ULJEE S, et al. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J Pathol. 2008; 215: 222-30. http://dx.doi.org/10.1002/path.2347
44. WHITESIDE TL, FERRONE S. For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top. Clin Cancer Res. 2012; 18: 2417-9. http://dx.doi.org/10.1158/1078-0432.CCR-12-0566
45. LEE C, BONGCAM-RUDLOFF E, SOLLNER C, JAHNENDECHENT W, CLAESSON-WELSH L. Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci. 2009; 14: 2911-22. http://dx.doi.org/10.2741/3422
46. HAMM A, VEECK J, BEKTAS N, WILD PJ, HARTMANN A, et al. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer. 2008; 8: 25. http://dx.doi.org/10.1186/1471-2407-8-25
47. CHONG P. K, LEE H, ZHOU J, LIU SC, LOH MC, et al. ITIH3 is a potential biomarker for early detection of gastric cancer. J Proteome Res. 2010; 9: 3671-9. http://dx.doi.org/10.1021/pr100192h